Global Omeprazole Market Outlook 2017-2022

November 2017 | 97 pages | ID: G776BD638A8EN
Gen Consulting Company

Abstracts

Omeprazole, sold under the brand names Prilosec and Losec among others, is a medication used in the treatment of gastroesophageal reflux disease, peptic ulcer disease, and Zollinger–Ellison syndrome. It is also used to prevent upper gastrointestinal bleeding in people who are at high risk. It can be taken by mouth or injected into a vein.

The report covers forecast and analysis for the omeprazole market on a global and regional level. The study provides historic data of 2012-2016 along with a forecast from 2017 to 2022 based on both output/volume and revenue. The study then describes the drivers and restraints for the omeprazole market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the omeprazole market on a global level.

The report has been prepared based on the synthesis, analysis, and interpretation of information about the global omeprazole market collected from specialized sources. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. Company overview, financial overview, product portfolio, new project launched, recent development analysis are the parameters included in the profile. Relevantly, the report and company profiles specify the key drivers that are impacting the demand in global omeprazole market.

Key Regions

• North America
• Europe
• Asia Pacific

Key Vendors

• AstraZeneca
• Lupin
• Oneiro Chemicals
• Cadila Healthcare
• Dr Reddys
• Hetero Drugs
• Sun Pharmaceutical
• ZHP
• request free sample to get a complete list of companies

Key Questions Answered in this Report

• What will the market size be in 2022?
• What are the key factors driving the global omeprazole market?
• What are the challenges to market growth?
• Who are the key players in the omeprazole market?
• What are the market opportunities and threats faced by the key players?

Contents

PART 1. EXCLUSIVE SUMMARY

PART 2. METHODOLOGY

2.1 Research Methodology
2.2 Geographic Scope
2.3 Years Considered

PART 3. INTRODUCTION

3.1 Product Overview
3.2 Manufacturing Process

PART 4. COMPETITIVE LANDSCAPE

4.1 Global Omeprazole Market, by Volume 2012-2017
  4.1.1 Overview
  4.1.2 Global Omeprazole Market, by Volume, by Company
  4.1.3 Top 3 Companies by Volume Share
4.2 Global Omeprazole Market, by Revenue 2012-2017
  4.2.1 Overview
  4.2.2 Global Omeprazole Market, by Revenue, by Company
  4.2.3 Top 3 Companies by Revenue Share

PART 5. MARKET DYNAMICS

5.1 Market Drivers
5.2 Challenges
5.3 Market Trends

PART 6. SEGMENTATION BY REGION

6.1 Global Omeprazole Volume by Region
  6.1.1 North America
  6.1.2 Europe
  6.1.3 Asia-Pacific
6.2 Global Omeprazole Revenue by Region
  6.2.1 North America
  6.2.2 Europe
  6.2.3 Asia-Pacific

PART 7. CONSUMPTION PATTERN

7.1 North America
  7.1.1 Overview
  7.1.2 by Country (U.S., Canada, etc.)
7.2 Europe
  7.2.1 Overview
  7.2.2 by country (Germany, UK, France, etc.)
7.3 Asia-Pacific
  7.3.1 Overview
  7.3.2 by Country (China, Japan, India, etc.)

PART 8. OMEPRAZOLE MARKET FORECAST

8.1 Global Omeprazole Market Size 2017-2022
8.2 Global Omeprazole Market by Region 2017-2022
  8.2.1 North America
  8.2.2 Europe
  8.2.3 Asia-Pacific
8.3 Global Omeprazole Consumption 2017-2022

PART 9. KEY VENDORS

9.1 Company Profiles
9.2 Market Share
9.3 Financials

PART 10. INDUSTRY ACTIVITY

10.1 M&As, JVs and Partnership
10.2 Other Developments

PART 11. APPENDIX

11.1 Abbreviations
11.2 Disclaimer